Clinical Trial Update: Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 proof-of-principle study evaluating Gonyautoxins NEURO SERUM for chemotherapy-induced peripheral neuropathy; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Gonyautoxins NEURO SERUM

Snippet

Sponsor: Algenis SpA | Conditions: Chemotherapy-induced Peripheral Neuropathy | Phase 1, Phase 2 | Status: UNKNOWN